These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27725107)

  • 1. New feasible treatment for refractory autoimmune encephalitis: Low-dose interleukin-2.
    Lim JA; Lee ST; Moon J; Jun JS; Park BS; Byun JI; Sunwoo JS; Park KI; Jung KH; Jung KY; Lee SK; Chu K
    J Neuroimmunol; 2016 Oct; 299():107-111. PubMed ID: 27725107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study.
    Lee WJ; Lee ST; Moon J; Sunwoo JS; Byun JI; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Kim S; Park KI; Jung KH; Jung KY; Kim M; Lee SK; Chu K
    Neurotherapeutics; 2016 Oct; 13(4):824-832. PubMed ID: 27215218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
    Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
    J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Clinical Characteristics and Poor Prognostic Predictors in Patients With an Initial Diagnosis of Autoimmune Encephalitis.
    Qiu X; Zhang H; Li D; Wang J; Jiang Z; Zhou Y; Xu P; Zhang J; Feng Z; Yu C; Xu Z
    Front Immunol; 2019; 10():1286. PubMed ID: 31231392
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study.
    Byun JI; Lee ST; Jung KH; Sunwoo JS; Moon J; Lim JA; Lee DY; Shin YW; Kim TJ; Lee KJ; Lee WJ; Lee HS; Jun J; Kim DY; Kim MY; Kim H; Kim HJ; Suh HI; Lee Y; Kim DW; Jeong JH; Choi WC; Bae DW; Shin JW; Jeon D; Park KI; Jung KY; Chu K; Lee SK
    PLoS One; 2016; 11(1):e0146455. PubMed ID: 26771547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadsorption for autoimmune encephalitis.
    Fassbender C; Klingel R; Köhler W
    Atheroscler Suppl; 2017 Nov; 30():257-263. PubMed ID: 29096847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.
    Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L
    J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib treatment for refractory autoimmune encephalitis.
    Jang Y; Lee WJ; Lee HS; Chu K; Lee SK; Lee ST
    Epilepsia; 2021 Apr; 62(4):e53-e59. PubMed ID: 33656171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on clinical features and factors related to long-term outcomes of antibody-negative autoimmune encephalitis.
    Han B; Dai Y; Peng J; Yuan T; Yin Q; Yang L
    Ann Clin Transl Neurol; 2024 May; 11(5):1325-1337. PubMed ID: 38644648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.
    Wickel J; Chung HY; Platzer S; Lehmann T; Prüss H; Leypoldt F; Günther A; Scherag A; Geis C;
    Trials; 2020 Jul; 21(1):625. PubMed ID: 32641101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset refractory status epilepticus: Etiology, clinical features, and outcome.
    Gaspard N; Foreman BP; Alvarez V; Cabrera Kang C; Probasco JC; Jongeling AC; Meyers E; Espinera A; Haas KF; Schmitt SE; Gerard EE; Gofton T; Kaplan PW; Lee JW; Legros B; Szaflarski JP; Westover BM; LaRoche SM; Hirsch LJ;
    Neurology; 2015 Nov; 85(18):1604-13. PubMed ID: 26296517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis.
    Jang Y; Lee ST; Kim TJ; Jun JS; Moon J; Jung KH; Park KI; Chu K; Lee SK
    Sci Rep; 2018 Jan; 8(1):1012. PubMed ID: 29343812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Ofatumumab treatment in anti-DPPX autoimmune encephalitis.
    Fu P; Hu Z; Zhang G; Li Z
    Front Immunol; 2024; 15():1320608. PubMed ID: 39007139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune encephalitis and immune therapy: lessons from Argentina.
    Melamud LI; Fernández VC; Manin A; Villa AM
    Acta Neurol Belg; 2020 Jun; 120(3):565-572. PubMed ID: 30182259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmalaria Neurologic Syndrome-Autoimmune Encephalitis With Anti-Voltage-Gated Potassium-Channel Antibodies.
    Sahuguet J; Poulet A; Bou Ali H; Parola P; Kaphan E
    Ann Intern Med; 2017 Jul; 167(1):70-71. PubMed ID: 28505668
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy in autoimmune encephalitis - A need for "presumptive" diagnosis and treatment.
    Pradhan S; Das A; Mani VE
    Neurol India; 2018; 66(6):1584-1589. PubMed ID: 30504544
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hashimoto's encephalopathy].
    Yoneda M
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():603-6. PubMed ID: 26480764
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review.
    DeSena AD; Noland DK; Matevosyan K; King K; Phillips L; Qureshi SS; Greenberg BM; Graves D
    J Clin Apher; 2015 Aug; 30(4):212-6. PubMed ID: 25664728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune encephalitis, clinical, radiological and immunological data].
    Aupy J; Collongues N; Blanc F; Tranchant C; Hirsch E; De Seze J
    Rev Neurol (Paris); 2013 Feb; 169(2):142-53. PubMed ID: 23099105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study.
    Gastaldi M; Mariotto S; Giannoccaro MP; Iorio R; Zoccarato M; Nosadini M; Benedetti L; Casagrande S; Di Filippo M; Valeriani M; Ricci S; Bova S; Arbasino C; Mauri M; Versino M; Vigevano F; Papetti L; Romoli M; Lapucci C; Massa F; Sartori S; Zuliani L; Barilaro A; De Gaspari P; Spagni G; Evoli A; Liguori R; Ferrari S; Marchioni E; Giometto B; Massacesi L; Franciotta D
    Eur J Neurol; 2020 Apr; 27(4):633-643. PubMed ID: 31814224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.